Sentinel node biopsy in breast cancer: Short time results show appropriate regional control

Neoplasma

Volumn 54, Issue 3, 2007, Pages 256-261

  Fait, V ^a   Chrenko, V ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Breast cancer; Lymphadenectomy; Recurrence; Sentinel node biopsy; Staging

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL; TUMOR VOLUME; BREAST TUMOR; FEMALE; LYMPHADENECTOMY; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 34347214811     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hubalewska-Dydejczyk A, Sowa-Staszczak A, Huszno B.: Current application of sentinel lymph node lymphoscintigraphy to detect various cancer metastases. Hell J Nucl Med. 2006; 9: 5-9.
2. Bowers K, Liu Y, Ghesani N. et al.: A level III sentinel lymph node in breast cancer. World J Surg Oncol. 2006; 4: 31 (Pubitemid 44322139)
3. Nagashima T, Sakakibara M, Nakano S. et al.: Sentinel node micrometastasis and distant failure in breast cancer patients. Breast Cancer. 2006;13: 186-191
4. Mittendorf EA, Arciero CA, Gutchell V, et al..: Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg. 2005; 62: 253-257
5. Moran CJ, Kell MR, Kerin MJ.: The role of sentinel lymph node biopsy in ductal carcinoma in situ. Eur J Surg Oncol. 2005; 31: 1105-1111 (Pubitemid 41819193)
6. Gatěk J, Duben J, Hnátek L, Bakala J, Dudešek B, Goldmanová B.: Surgical therapy of the intraductal breast cancer. Rozhl Chir. 2004; 83: 597-603. (In Czech).
7. Thomas A, Ohlinger R, Hauschild M, Mustea A, Blohmer JU, Kummel S. Options and limits of surgery after pre-operative chemotherapy in breast cancer. Anticancer Res. 2006; 26: 1677-1682
8. Fait, V., Chrenko, V., Gatěk, J.: Sentinel biopsy in the breast cancer and neoadjuvant chemotherapy. Klinická onkologie, 2005; 18: 77-79 (In Czech).
9. Canavese G, Gipponi M, Catturich A, et al..: Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery. J Surg Oncol. 2000; 74: 61-68 (Pubitemid 30387225)
10. Radovanovic Z, Golubovic A, Plzak A, et al.: Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol. 2004; 30: 913-917 (Pubitemid 39462518)
11. Burak WE, Hollenbeck ST, Zervos EE, et al.: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002; 183: 23-27 (Pubitemid 34178601)
12. Giuliano AE, Dale PS, Turner RR, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995; 222: 394-399
13. Turner RR, Ollila DW, Krasne DL, et al.: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997; 226: 271-276
14. Chu KU, Turner RR, Hansen NM, et al.: Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol. 1999; 6: 756-761 (Pubitemid 30013652)
15. Veronesi U, Paganelli G, Viale G, .: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003; 349: 546-553 (Pubitemid 36951366)
16. Nieweg OE, Rutgers EJ, Jansen L, et al.: Is lymphatic mapping in breast cancer adequate and safe? World J Surg. 2001; 25: 780-788
17. Wong SL, Abell TD, Chao C, et al.: Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: a decision analysis. Cancer. 2002; 95: 478-487 (Pubitemid 34810172)
18. Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg. 2001; 136: 688-692 (Pubitemid 32525473)
19. Katz A, Niemierko A, Gage I, et al.: Can axillary dissection be avoided in patients with sentinel lymph node metastasis? J Surg Oncol. 2006; 93: 517-518
20. Travagli JP, Atallah D, Mathieu MC, et al.: Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol. 2003; 29: 403-406 (Pubitemid 36675702)
21. Carmon M, Olsha O, Schecter WP, et al.: The "Sentinel Chain": a new concept for prediction of axillary node status in breast cancer patients. Breast Cancer Res Treat. 2006; 97: 323-328
22. Motomura K, Egawa C, Komoike Y,.: Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases. Ann Surg Oncol. 2006; 13: 985-989 (Pubitemid 43920932)
23. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 1999; 17: 1720-1726
24. van Rijk MC, Peterse JL, Nieweg OE, et al.: Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer. 2006; 107: 467-471 (Pubitemid 44107205)
25. Reitsamer R, Peintinger F, Prokop E, et al.: 200 Sentinel lymph node biopsies without axillary lymph node dissection - no axillary recurrences after a 3-year follow-up. Br J Cancer. 2004; 90: 1551-1554 (Pubitemid 38648237)
26. van der Vegt B, Doting MH, Jager PL, et al.: Axillary recurrence after sentinel lymph node biopsy. Eur J Surg Oncol. 2004; 30: 715-720 (Pubitemid 39107060)
27. Langer I, Marti WR, Guller U, et al.: Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg. 2005; 241: 152-158 (Pubitemid 40041004)
28. Haid A, Knauer M, Koberle-Wuhrer R.et al.: Medium-term follow-up data after sentinel node biopsy alone for breast cancer. Eur J Surg Oncol. 2006; 32: 1180-1185 (Pubitemid 44793674)